Q: What is a “stem cell”?
A: Stem cells are a group of cells with the ability to self-renew, proliferate rapidly, and differentiate into multiple cell types.
Q: What are “Autologous Pluripotent Potential Cells”?
A: Autologous Pluripotent Potential Cells are stem cells derived from an individual’s own white blood cells. They include a variety of stem cell types such as hematopoietic stem cells, mesenchymal stem cells, endothelial stem cells, and very small embryonic-like stem cells (VSELs). These cells exhibit enhanced expression of pluripotency genes (OCT4, NANOG, SOX2) and the self-renewal gene TERT. They possess the ability to differentiate into all three germ layers (ectoderm, mesoderm, endoderm), exhibit homing effects, and can target damaged tissues after autologous infusion to initiate regenerative responses. They hold strong therapeutic potential for self-healing.
Q: What conditions can Autologous Pluripotent Potential Cell products be applied to?
A: They can be used for various clinical conditions, including kidney disease, cardiovascular disease, liver, gallbladder and gastrointestinal disorders, leukemia, hormonal imbalances, male and female infertility, osteoarthritis, joint degeneration, metabolic syndrome, neurological disorders, immune dysfunction, sexual dysfunction, and aesthetic medicine (such as hair follicle regeneration and replacing fillers like hyaluronic acid).
Q: Are there any side effects from autologous infusion of Autologous Pluripotent Potential Cell products?
A: As of May 2023, over 2,000 autologous intravenous infusion cases have been completed in more than 500 individuals, with no adverse reactions or side effects reported. The treatment is clinically safe.
Q: Are there any dietary restrictions before or after autologous infusion of Autologous Pluripotent Potential Cell products?
A: Within 72 hours before and after the treatment, avoid consuming probiotic-containing foods (to prevent potential allergic reactions) and do not consume alcohol.
Q: How many days does the entire autologous infusion process of Autologous Pluripotent Potential Cells take?
A: The full process takes 5 days.
Q: Besides intravenous infusion, are there other methods of administration for Autologous Pluripotent Potential Cells?
A: Yes, in addition to intravenous infusion, the cells can also be administered via joint injection or subcutaneous injection (for aesthetic purposes).
Q: Can Autologous Pluripotent Potential Cells be used by close relatives such as parents, children, or siblings?
A: No, they are strictly for autologous use and cannot be used on anyone else, including immediate family members or siblings.
Q: Who should not undergo treatment with Autologous Pluripotent Potential Cells?
A: This treatment is not suitable for pregnant women, individuals under 18 years of age, or those who have received a blood transfusion within the past 6 weeks.
Q: How can I inquire about undergoing treatment with Autologous Pluripotent Potential Cells?
A:
Phone: +886-919-255528
Email: service@ld-global.net